首页> Clinical chemistry and laboratory medicine> Failure Mode and Effects Analysis (FMEA) at the preanalytical phase for POCT blood gas analysis: proposal for a shared proactive risk analysis model.

Failure Mode and Effects Analysis (FMEA) at the preanalytical phase for POCT blood gas analysis: proposal for a shared proactive risk analysis model.

导出原文传递

翻译打印收藏纠错

第一作者： Viviane,Van Hoof

第一单位： Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium.

作者： Viviane,Van Hoof ^[1] ; Suzanne,Bench ^[2] ; Antonio Buño,Soto ^[3] ; Peter P,Luppa ^[4] ; Anthony,Malpass ^[5] ; Ulf Martin,Schilling ^[6] ; Kevin D,Rooney ^[7] ; Adam,Stretton ^[5] ; Andrei N,Tintu ^[8]

作者单位： Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Belgium. ^[1] Guys and St Thomas NHS Foundation Trust, London, UK. ^[2] Pathology Department, La Paz Hospital, Madrid, Spain. ^[3] Institute for Clinical Chemistry and Pathobiochemistry, Technische Universität München, Munich, Germany. ^[4] Becton, Dickinson and Company, Wokingham, UK. ^[5] Department of Clinical Education, Test and Innovation, Linkoping University Hospital, Linkoping, Sweden. ^[6] Royal Alexandra Hospital, Paisley, UK. ^[7] Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands. ^[8]

关键词 blood gas analysis (BGA)failure mode and effects analysis (FMEA)patient safety point-of-care testing (POCT)preanalytical error risk management

医学主题词人类(Humans);概率(Probability);危险性评估(Risk Assessment)

DOI 10.1515/cclm-2022-0319

PMID 35607775

发布时间 2022-12-23

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交